HMLSF ETF — Holdings & Analysis

For informational purposes only. Not financial advice.

Quick Answer

The Global X Marijuana Life Sciences Index ETF (HMLSF) is designed to track the North American Marijuana Index, providing exposure to companies involved in the marijuana industry.

With assets under management (AUM) of $0.03 billion and an expense ratio of 1.00%, HMLSF offers a diversified approach to investing in the cannabis sector. The ETF rebalances quarterly to reflect the evolving landscape of the marijuana industry, capturing shifts in leadership and growth drivers.

Global X Marijuana Life Sciences Index ETF (HMLSF) ETF — Price, Holdings & Analysis

The Global X Marijuana Life Sciences Index ETF (HMLSF) is designed to track the North American Marijuana Index, providing exposure to companies involved in the marijuana industry. With assets under management (AUM) of $0.03 billion and an expense ratio of 1.00%, HMLSF offers a diversified approach to investing in the cannabis sector. The ETF rebalances quarterly to reflect the evolving landscape of the marijuana industry, capturing shifts in leadership and growth drivers.

ETF Overview

HMMJ seeks to closely replicate the performance of the North American Marijuana Index. This index is specifically crafted to offer exposure to a diversified basket of North American publicly listed companies heavily involved in the marijuana industry. Unlike investing in a single marijuana company, HMMJ offers diversified exposure to a basket of North American publicly listed companies within the industry, reducing the risk associated with individual securities while still capturing the potential upside of the sector. With the marijuana industry rapidly evolving, HMMJ is rebalanced quarterly to ensure the portfolio reflects the changing landscape, providing investors with exposure to the industry's shifting leadership and growth drivers. HMMJ seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry

HMLSF aims to replicate the performance of the North American Marijuana Index, offering investors exposure to a basket of North American publicly listed companies with significant business activities in the marijuana industry. This ETF provides a diversified approach to investing in the cannabis sector, reducing the risks associated with investing in individual marijuana companies. The fund's quarterly rebalancing ensures that the portfolio remains aligned with the evolving dynamics of the industry, capturing emerging trends and key players. The fund's country exposure is primarily focused on Canada (51.2%) and the United States (34.3%), with smaller allocations to Ireland (11.6%) and Australia (2.6%). HMLSF is designed for investors seeking targeted exposure to the marijuana industry through a diversified portfolio of companies involved in various aspects of the business, from cultivation and retail to pharmaceuticals and biotechnology.

Risk Metrics

HMLSF's concentration in the marijuana industry presents a significant sector-specific risk. The ETF's performance is highly dependent on the regulatory environment, market sentiment, and competitive dynamics within the cannabis sector. The fund's relatively small AUM of $0.03 billion could pose liquidity risks, potentially leading to wider bid-ask spreads and greater price volatility. The expense ratio of 1.00% is relatively high, which can create a drag on returns, especially when compared to broader market equity ETFs. Investors should also consider the geographic concentration, with a significant portion of the fund's holdings in Canada and the United States, exposing it to regulatory and economic risks specific to these regions. Past performance does not guarantee future results.

Expense Ratio

1.00%

How Is the Fund Allocated?

Country	Weight
Canada	51.2%
United States	34.3%
Ireland	11.6%
Australia	2.6%
Other	0.3%

Dividend Yield

0.00%

iShares Russell 2000 ETF (IWM) — 0.19% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
iShares MSCI Emerging Markets ETF (EEM) — 0.72% expense ratio
iShares MSCI EAFE ETF (EFA) — 0.32% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
State Street SPDR S&P 500 ETF (SPY) — 0.09% expense ratio

Global X - MSCI Colombia ETF (GXG) (Equity) — 0.62% expense ratio
Global X China Innovation ETF (KEJI) (Equity) — 0.75% expense ratio
Global X - Genomics & Biotechnology ETF (GNOM) (Equity) — 0.50% expense ratio
Global X - MSCI SuperDividend EAFE ETF (EFAS) (Equity) — 0.55% expense ratio
Global X - Adaptive U.S. Risk Management ETF (ONOF) (Equity) — 0.39% expense ratio
Global X Funds - Global X Nasdaq 100 ESG Covered Call ETF (QYLE) (Equity) — 0.61% expense ratio

Questions & Answers

What is HMLSF and what does it track?

The Global X Marijuana Life Sciences Index ETF (HMLSF) seeks to replicate the performance of the North American Marijuana Index.

This index is designed to provide exposure to North American publicly listed companies with significant business activities in the marijuana industry.

What is the expense ratio for HMLSF?

The expense ratio for HMLSF is 1.00%. This means that for every $1000 invested in the ETF, $10 is used to cover the fund's operating expenses.

This expense ratio is higher than the average expense ratio for equity ETFs, which is around 0.44%. The expense ratio as it can impact the overall returns of the ETF over time may be worth researching.

Is HMLSF a good long-term investment?

Whether HMLSF is a suitable long-term investment depends on an individual's investment goals, risk tolerance, and belief in the long-term growth potential of the marijuana industry.

The ETF offers exposure to a rapidly evolving sector, but it also carries significant risks, including regulatory uncertainty, market volatility, and competition. The fund's expense ratio of 1.00% can also impact long-term returns. Past performance does not guarantee future results.

How does HMLSF compare to similar ETFs?

HMLSF competes with other ETFs that focus on the cannabis industry. Key differentiators include the underlying index, portfolio composition, expense ratio, and AUM. HMLSF has an expense ratio of 1.00% and AUM of $0.03 billion.

Comparing these metrics to similar ETFs can help investors determine which fund best aligns with their investment objectives and risk tolerance.

Does HMLSF pay dividends?

Based on the provided data, HMLSF has a dividend yield of 0.00%. This indicates that the ETF does not currently distribute dividends to its shareholders.

Investors seeking income-generating investments may want to consider other ETFs with a history of dividend payments. However, the lack of dividends does not necessarily make HMLSF an unsuitable investment, as the fund's primary objective is capital appreciation through exposure to the marijuana industry.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

Written by machine, not reviewed page by page. Editorial oversight is systemic: the rules and the sources are checked, individual pages are not.